We have developed a two-step, real-time, quantitative assay, using the polymerase chain reaction with reverse transcription (RT-PCR) and based on SYBR Green I monitoring of PCR product ...
D'Arcy brought a landmark legal challenge against US-based biotech company Myriad Genetics after it was granted a patent over the BRCA1 and BRCA2 genes. Mutations in the genes dramatically increase a ...